http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010531371-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C43-168 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00 |
| filingDate | 2008-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2010531371-A |
| titleOfInvention | Hydrolyzable polymer FMOC-linker |
| abstract | The present invention relates to polymer conjugates based on Fmoc (9-fluorenyl-methoxycarbonyl). These conjugates are useful for extending the in vivo circulation of protein and peptide drugs. In one embodiment, the present invention relates to at least one semi-synthetic biopolymer in which a hydrolyzable linker is conjugated to a protein or peptide drug to improve in vivo properties, such as in vivo circulation. A coupled hydrolyzable linker is provided. |
| priorityDate | 2007-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.